Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
株式のランク #28166
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
株価
$0.5495
最終同期: 2025-05-15
時価総額
$28.14M
変化(1日)
4.70%
変化(1年)
0.00%
US
取引 Enzo Biochem, Inc. (ENZ)

カテゴリー

Enzo Biochem, Inc.(ENZ)の営業利益率
August 2026 時点の営業利益率 TTM: -30.77%
Enzo Biochem, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -30.77% です。2023 年末時点では -79.64% でした。
Enzo Biochem, Inc. の営業利益率の履歴(2000 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -30.77% 0.00%
2024 -30.77% -61.36%
2023 -79.64% 450.00%
2022 -14.48% -272.59%
2021 8.39% -126.99%
2020 -31.09% -132.30%
2019 96.26% -928.40%
2018 -11.62% 309.15%
2017 -2.84% -106.21%
2016 45.73% -3,787.90%
2015 -1.24% -88.31%
2014 -10.61% -47.60%
2013 -20.25% -48.43%
2012 -39.27% 209.94%
2011 -12.67% -44.23%
2010 -22.72% -15.41%
2009 -26.86% 41.29%
2008 -19.01% -52.03%
2007 -39.63% -21.68%
2006 -50.60% 113.14%
2005 -23.74% -19.17%
2004 -29.37% -454.71%
2003 8.28% -50.24%
2002 16.64% 5.32%
2001 15.80% 55.51%
2000 10.16% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.69% -100.57%
US
20.42% -100.66%
US
0.00% -
CN
-10.70% -99.65%
US
32.03% -101.04%
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。